J
John C. Sherris
Researcher at University of Washington
Publications - 27
Citations - 18955
John C. Sherris is an academic researcher from University of Washington. The author has contributed to research in topics: Cefamandole & Enterobacter. The author has an hindex of 18, co-authored 27 publications receiving 17548 citations. Previous affiliations of John C. Sherris include University of Rochester & University of Minnesota.
Papers
More filters
Journal ArticleDOI
Emergence in a Burn Center of Populations of Bacteria Resistant to Gentamicin, Tobramycin, and Amikacin: Evidence for the Need for Changes in Zone Diameter Interpretative Standards
TL;DR: Criteria for gentamicin disk diffusion testing should include an intermediate or indeterminate category, and that the limits of the intermediate category for tobramycin and amikacin should be expanded.
Journal ArticleDOI
Electrical Impedance Measurements in the Reading and Monitoring of Broth Dilution Susceptibility Tests
H. J. Colvin,John C. Sherris +1 more
TL;DR: In this paper, electrical impedance changes in the medium were studied during traditional broth dilution tests and the correlation between the 6-h impedance MIC and the overnight visual MIC was improved to 74%.
Journal ArticleDOI
Microbiological studies of intestinal biopsies taken during active whipple's disease.
TL;DR: It is concluded that the bacilliform bodies, assuming them to be bacteria, were highly fastidious, and that their growth requirements were not met in these experiments.
Journal ArticleDOI
In vitro response of Enterobacter to ampicillin.
TL;DR: Three strains of Enterobacter were studied for their response to ampicillin and both mutants showed cross-resistance to other beta-lactam antibiotics, explaining discrepancies between traditional broth dilution minimum inhibitory concentration tests and early read automated procedures.
Journal ArticleDOI
Reproducibility of control strains for antibiotic susceptibility testing.
TL;DR: Inter- and intralaboratory reproducibility of susceptibility testing requires stable control strains and the Seattle strains of Staphylococcus aureus and Escherichia coli are recommended for this purpose.